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Background:  Early revascularization leads to improved outcome in patients (pts) with acute coronary syndrome (ACS). Elderly ACS pts are less 
likely to receive evidence-based treatment, including revascularization therapy, due to uncertainty of associated benefits and risks.
Methods:  953 elderly pts (age>75) admitted with ACS from 1999-2007 were identified at a large referral hospital. We retrospectively studied 6 
months and 2 year outcomes (death, readmit for ACS), comparing pts who were revascularized (primary angioplasty [PCI], and coronary artery bypass 
surgery [CABG]) versus pts not revascularized.
Results: 360 pts were revascularized; 593 were not. Non revascularized pts tended to be older, (82.3±5.1 vs 80.4±4.3 p<0.001), had a lower 
weight (157±34 vs 170±61 pounds, p<0.001), and higher creatinine level on admit (1.46±1.10 vs1.3±0.87, p=0.018). They presented less 
frequently as STEMI (16.2% vs 30.3%, p<0.001) and more frequently with unstable angina (27.7% vs 13.6%, p<0.001). Rehospitalization rates for 
ACS at 6 months (32.0% vs 36.7%, p=0.194), and 2 years (50.4% vs 42.9%, p=0.130) were comparable. The 6 month (18.5% vs 6.4%, p<0.001), 
and 2 year death rates (43.6% vs 17.6%, p<0.001) were higher in non-revascularized vs revascularized. This difference in outcome persisted in 
pts aged 75 to 80 years [death at 6 months (15.0% vs 4.8%, p=0.001); death at 2 years (36.7% vs 17.6%, p<0.001)]; and in pts aged 80 to 
85 years[death at 6 months (22.2% vs 6.3%, p=0.001); death at 2 years, (43.0% vs 15.5%, p<0.001)]. In pts aged 85 and older, the 6 month 
death rate was not different (19.7% vs 12.8%, p=0.278), but the 2 year death rate showed significant difference, (53.2% vs 21.7%, p<0.001, 
revascularized vs non-revascularized, respectively).In multiple logistic regression analysis, after adjustment for age,gender, peak creatinine , 
diabetes, EF(%), and discharge medications , revascularization (PCI and CABG) remained protective for 2-year mortality in the elderly (PCI: OR=0.51, 
95% CI 0.29-0.89, p=0.02; CABG: OR=0.066, 95% CI 0.009-0.51, p=0.009).
Conclusions:  Elderly pts benefit from revascularization up to 2 years after ACS. This benefit persists even in pts aged 85 and older.
